^
HR positive + HER-2 negative
Male Breast Cancer
tamoxifen
Sensitive
:
A2
No biomarker
Male Breast Cancer
HER2 inhibitor
Sensitive
:
A2
HR positive + HER-2 negative
Male Breast Cancer
fulvestrant
Sensitive
:
A2
HR positive
Male Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
HR positive
Male Breast Cancer
tamoxifen
Sensitive
:
A2
ER positive
Male Breast Cancer
tamoxifen
Sensitive
:
A2
PIK3CA mutation + HR positive + HER-2 negative
Male Breast Cancer
alpelisib
Sensitive
:
A2
HR positive + HER-2 negative
Male Breast Cancer
ribociclib
Sensitive
:
B
HR positive + HER-2 negative
Male Breast Cancer
palbociclib
Sensitive
:
C3